News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

June 10, 2026
June 10, 2026
Categories

Press Release: Elsa Anagnostou, Jordan Berlin, and Olisaemeka Ogbue receive ECOG-ACRIN 2026 scientific leadership and mentorship awards

Do you like it?
Read more
June 4, 2026
June 4, 2026
Categories

A new exploratory analysis from STAMP (EA6174) on aggressive Merkel cell cancer draws attention at ASCO 2026

Do you like it?
Read more
June 2, 2026
June 2, 2026
Categories

EA5142, an ALCHEMIST trial, adds to the knowledge base about optimal timing of adjuvant immunotherapy in non-small cell lung cancer

Do you like it?
Read more
June 2, 2026
June 2, 2026
Categories

WATCH: Dr. Jamie Chaft discusses the results of ALCHEMIST EA5142, a randomized phase 3 study of nivolumab after surgery and adjuvant chemotherapy in non-small cell lung cancer

Do you like it?
Read more
June 1, 2026
June 1, 2026
Categories

JAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce the risk of recurrence in patients with resected non-small cell lung cancer

Do you like it?
Read more
May 28, 2026
May 28, 2026
Categories

The May 2026 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
May 21, 2026
May 21, 2026
Categories

Press Release: Guide to ECOG-ACRIN cancer research at ASCO 2026

Do you like it?
Read more
May 19, 2026
May 19, 2026
Categories

Press Release: TAILORx and RxPONDER trials shift to a discovery platform for analyzing breast cancer recurrence using advanced tumor profiling and AI

Do you like it?
Read more
May 15, 2026
May 15, 2026
Categories

The Spring 2026 advocacy blog Considering Clinical Trials is now available

Do you like it?
Read more
April 27, 2026
April 27, 2026
Categories

The April 2026 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
April 8, 2026
April 8, 2026
Categories

ECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials

Do you like it?
Read more
April 8, 2026
April 8, 2026
Categories

Group co-chair Dr. Mitchell Schnall named a health system chief digital officer to know in 2026

Do you like it?
Read more
March 30, 2026
March 30, 2026
Categories

The March 2026 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
March 24, 2026
March 24, 2026
Categories

ECOG-ACRIN study finds inferior survival among Black patients with AML, independent of cytogenetic risk

Do you like it?
Read more
March 19, 2026
March 19, 2026
Categories

Press Release: ECOG-ACRIN completes enrollment for 600-patient clinical trial focused on frontline treatment for advanced melanoma

Do you like it?
Read more
March 4, 2026
March 4, 2026
Categories

Press Release: ECOG-ACRIN Cancer Research Group announces the retirement of Robert Gray after 25 years as group statistician

Do you like it?
Read more
March 2, 2026
March 2, 2026
Categories

Announcement: Group Statistician, Therapeutics, Leadership Transition

Do you like it?
Read more
February 27, 2026
February 27, 2026
Categories

The February 2026 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
February 27, 2026
February 27, 2026
Categories

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD, Health Equity Travel Scholarship to attend the Spring 2026 Group Meeting

Do you like it?
Read more
February 27, 2026
February 27, 2026
Categories

Attention CRAs: Travel funds are available for the Spring 2026 Group Meeting (apply now)

Do you like it?
Read more
Load more
News and Info

News

News and Info
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Categories


Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Artificial intelligence (AI) Bladder cancer Breast cancer Cancer Research Cancer screening Cancer treatment Chemotherapy Clinical trial ComboMATCH Disparities Gastric cancer Geriatric oncology GI cancer Group meeting Head and neck cancer Health equity Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma Myeloma NCI-MATCH Pancreatic cancer Personalized screening Precision medicine Precision oncology Prostate cancer Radiology Research results Sarcoma Skin cancer Social determinants of health Stomach cancer Survivorship Targeted therapy TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group